Health outcome estimates
Parameters | All | 0–4 | 5–14 | 15–44 | 45–64 | 65+ | Source* |
---|---|---|---|---|---|---|---|
*Reference numbers in square brackets. | |||||||
VZIG, varicella zoster immune globulin; PHN, post-herpetic neuralgia. | |||||||
% cases consult GP | |||||||
Natural varicella | 45% | 45% | 72% | 82% | 100% | [12] | |
Breakthrough varicella | 45% | 45% | 72% | 82% | 100% | [12,13] | |
Zoster | 100% | 100% | 100% | 100% | 100% | [12] | |
Number of visits per consultation | |||||||
Natural varicella | 1.18 | 1.24 | 1.29 | 1.40 | 1.43 | [12] | |
Breakthrough varicella | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | Assumption | |
Zoster | 1.07 | 1.18 | 1.36 | 1.43 | 1.68 | [12] | |
Hospitalisations per case | |||||||
Natural varicella | 0.37% | 0.14% | 0.62% | 1.38% | 3.14% | [12] | |
Breakthrough varicella | 0.07% | 0.03% | 0.12% | 0.28% | 0.63% | [12,14] | |
Zoster | 1.12% | 0.66% | 0.50% | 0.60% | 2.28% | [12] | |
Length of stay | |||||||
Natural varicella | 2.22 | 2.96 | 3.97 | 5.77 | 10.57 | [12] | |
Breakthrough varicella | 2.22 | 2.96 | 3.97 | 5.77 | 10.57 | [12] | |
Zoster | 3.53 | 3.35 | 4.58 | 5.23 | 13.54 | [12] | |
Case fatality | |||||||
Natural varicella | 0.001% | 0.001% | 0.009% | 0.073% | 0.689% | [12] | |
Zoster | 0.000% | 0.001% | 0.002% | 0.002% | 0.061% | [12] | |
VZIG per case | 0.2% | 0.2% | 3.3% | 0.2% | 0.2% | PHLS | |
PHN per zoster case | 0% | 1% | 4% | 11% | 31% | [17] | |
Duration of PHN (days) | 511 | [17] | |||||
QALY lost per case | |||||||
Natural varicella | 0.004 | 0.004 | 0.005 | 0.005 | 0.005 | See methods | |
Breakthrough varicella | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | Assumption | |
Zoster | 0.010 | [17] | |||||
PHN | 0.462 | [17] |